Search results
TIME100 Health: Katalin Kariko and Drew Weissman
Time Magazine· 5 days agoDr. Drew Weissman was working on developing an HIV vaccine, and Katalin Kariko was struggling to keep her lab open and convince her superiors that her...
Ziyad Al-Aly
Time Magazine· 5 days agoFind out why Ziyad Al-Aly is on the TIME100 Health list.
S2 Episode 5: Epidemiology of RSV in Adults
Medscape· 6 days agoFor more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Forest W....
Hologic (NASDAQ:HOLX) Releases Quarterly Earnings Results, Beats Expectations By $0.05 EPS
ETF DAILY NEWS· 3 days agoHologic (NASDAQ:HOLX – Get Free Report) posted its quarterly earnings data on Thursday. Hologic had a return on equity of 18.81% and a net margin of 11.78%. The company’s revenue for the quarter ...
Researchers develop algorithm to spot risk for dangerous preeclampsia
UPI· 1 day agoCanadian researchers at Université Laval in Québec City say they've developed an algorithm to spot...
Roche Unveils Upgraded GenMark Eplex MDx Platform at ESCMID Global
GenomeWeb News· 6 days agoAfter its 2021 acquisition of GenMark Diagnostics for $1.8 billion, Roche has upgraded the firm's flagship Eplex platform with new software and workflow components. The platform, which was officially ...
Ohio bill would limit the ability of employers to punish employees for not taking vaccines
Ohio Capital Journal via Yahoo News· 7 days agoA proposed Ohio House Bill would restrict the ability of an employer to punish employees for not...
Avoiding meat may help reverse advanced liver cirrhosis
UPI· 4 days agoPatients who stuck with a meat burger had higher blood levels of ammonia than those who consumed...
Amy Kirby
Time Magazine· 5 days agoFind out why Amy Kirby is on the TIME100 Health list.
Xencor, Inc. (NASDAQ:XNCR) Receives $36.00 Consensus PT from Analysts
ETF DAILY NEWS· 15 hours agoShares of Xencor, Inc. (NASDAQ:XNCR – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the nine analysts that are covering the firm, MarketBeat.com reports ...